SRC
TMO icon

Sage Rhino Capital’s Thermo Fisher Scientific TMO Stock Holding History

Sage Rhino Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
629
+4
+0.6% +$1.92K 0.05% 216
2026
Q1 		$307K Sell
625
-17
-3% -$9.23K 0.06% 188
2025
Q4 		$372K Sell
642
-24
-4% -$13.6K 0.07% 165
2025
Q3 		$323K Buy
666
+7
+1% +$3.26K 0.06% 181
2025
Q2 		$267K Sell
659
-24
-4% -$10K 0.06% 191
2025
Q1 		$340K Sell
683
-4
-0.6% -$2.17K 0.08% 159
2024
Q4 		$357K Sell
687
-5
-0.7% -$2.75K 0.08% 156
2024
Q3 		$428K Sell
692
-2
-0.3% -$1.18K 0.09% 148
2024
Q2 		$384K Buy
694
+14
+2% +$8.02K 0.09% 147
2024
Q1 		$395K Buy
680
+22
+3% +$12.3K 0.09% 146
2023
Q4 		$349K Sell
658
-26
-4% -$12.6K 0.09% 145
2023
Q3 		$346K Buy
684
+6
+0.9% +$3.2K 0.1% 144
2023
Q2 		$354K Sell
678
-45
-6% -$24.3K 0.1% 143
2023
Q1 		$417K Buy
723
+18
+3% +$10.1K 0.12% 133
2022
Q4 		$388K Hold
705
– – 0.12% 130
2022
Q3 		$358K Buy
705
+3
+0.4% +$1.68K 0.14% 111
2022
Q2 		$381K Sell
702
-8
-1% -$4.4K 0.15% 118
2022
Q1 		$419K Sell
710
-3
-0.4% -$1.72K 0.13% 136
2021
Q4 		$476K Buy
713
+7
+1% +$4.37K 0.13% 126
2021
Q3 		$403K Buy
706
+14
+2% +$7.68K 0.12% 124
2021
Q2 		$349K Buy
692
+244
+54% +$115K 0.1% 138
2021
Q1 		$204K Sell
448
-222
-33% -$106K 0.07% 168
2020
Q4 		$312K Buy
670
+2
+0.3% +$938 0.12% 123
2020
Q3 		$295K Buy
668
+2
+0.3% +$826 0.14% 116
2020
Q2 		$241K Buy
+666
New +$223K 0.13% 128
2020
Q1 		– Sell
-634
Closed -$208K – 163
2019
Q4 		$208K Buy
+634
New +$192K 0.12% 139

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sage Rhino Capital's TMO Position: Q2 2026 in Review

Sage Rhino Capital increased its Thermo Fisher Scientific (TMO) stake by 0.64% in Q2 2026, buying an estimated $1.92K and bringing the position to 629 shares worth $315K. The position accounts for 0.05% of the portfolio, ranked #216.

Sage Rhino Capital first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $476K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sage Rhino Capital held 629 shares of Thermo Fisher Scientific worth $315K as of Q2 2026.
  • Sage Rhino Capital bought 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
  • Thermo Fisher Scientific made up 0.05% of Sage Rhino Capital's portfolio in Q2 2026, its #216 holding.
  • Sage Rhino Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • Sage Rhino Capital's Thermo Fisher Scientific position peaked at $476K in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.